Clinical trial
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
NCT02205307 is registered in ClinicalTrials.gov with Novadaq Technologies ULC, now a part of Stryker as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
- Lead sponsor
- Novadaq Technologies ULC, now a part of Stryker
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- January 31, 2015
- Completion date
- May 31, 2017
- Enrollment
- 347 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.
rectal cancer, rectosigmoid cancer